New-Gen mRNA
Next-gen mRNA technologies enabling faster, cleaner, and highly efficient cell programming.
LEARN MORE
GMP iPSCs
Clinically compliant iPSC lines and banks offering long-term, reliable safety and performance stability.
LEARN MORE
Cell Therapy CDMO+
A full-spectrum iPSC-focused CDMO platform for development, manufacturing, and quality support.
LEARN MORE
Genome Editing
Precision genome engineering optimized for iPSC safety, stability, and therapeutic readiness.
LEARN MORE
iPSC Manufacturing & Quality
cGMP expansion and banking ensuring consistent, traceable, and clinic-ready iPSC sources.
LEARN MORE
WHY CHOOSE US
Empowering Therapies
That Transform Lives
01
Flexible, Scalable
Manufacturing
Our cGMP platform supports both clients’ processes and Allele’s proprietary workflows, offering early-stage accessibility, tech-transfer-friendly execution, and seamless scale-up/scale-out.
02
Over a Decades
of iPSC & cGMP
Leadership
From pioneering the world’s first cGMP iPSC facility to advancing mRNA reprogramming and differentiation, Allele brings 11+ years of deep, focused innovation in iPSC-based therapeutics.
03
Regulatory
Expertise &
Quality Assurance
Our development and QC systems follow rigorous cGMP, QMS, and analytical validation frameworks—ensuring compliance, reliability, and readiness for regulatory milestones at every stage.
04
iPSC Specialists Trusted by Innovators Worldwide
With validated iPSC lines, banks, and over two dozen differentiation protocols, we deliver scientifically robust and clinically aligned solutions trusted by global developers.
